GBT
GUERBET
Stock Euronext / Paris – Stock Market Prices, News & Analysis
GUERBET is a company specializing in contrast media for medical imaging, offering solutions for radiology and nuclear medicine.
GUERBET
GBT
GUERBET is a company specializing in contrast media for medical imaging, offering solutions for radiology and nuclear medicine.
Price history of GUERBET
Price history of GUERBET
Performance & Momentum
GUERBET Falls Despite Solid Results
GUERBET recently saw its share price drop sharply by 15% to EUR22.80, despite a positive annual revenue update showing 9% growth at constant exchange rates and on a like-for-like basis. Its EBITDA margin, after adjusting for exceptional costs, was in line with targets at 14.9%. The negative market reaction may reflect higher investor expectations or external concerns not specified in the report.
Strategic Analysis
GUERBET • 2026
Guerbet occupies a specialized niche in medical imaging, with significant exposure to contrast media and injectable solutions used in diagnostics. Its positioning is based on industrial and regulatory expertise that is difficult to replicate, serving a recurring healthcare market that is nonetheless subject to investment cycles and significant operational constraints.
- Specialist position in a niche segment of medical imaging
- Business supported by structural and recurring medical needs
- Pharmaceutical and technological know-how combining products, devices, and hospital uses
- Dependence on a narrow business scope, making it sensitive to demand and margin fluctuations
- Long-term depressed stock performance, reflecting confidence and execution weaknesses
Momentum is weak and the underlying trend remains clearly bearish, with market dynamics reflecting still-limited confidence in the Group’s turnaround. Strategically, the stock looks more like a turnaround story than a growth case, and tangible signs of operational improvement will be needed to reverse this unfavorable bias.
Similar stocks to GUERBET
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
